Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.
Global Medical REIT Inc., now Chiron Real Estate Inc., reports developments for a net-lease medical REIT that owns healthcare facilities leased to physician groups and regional and national healthcare systems. Company news centers on financial results, earnings calls, dividend declarations and tax treatment for common and preferred stock, and capital-structure actions involving preferred securities and indebtedness.
Updates also cover governance changes, shareholder voting matters, and the completed rebrand from Global Medical REIT to Chiron Real Estate, including the related ticker change and continuity of REIT qualification, organizational structure and stockholder rights.
Global Medical REIT Inc. (NYSE: GMRE) plans to release its Q2 2022 financial results after market close on August 3, 2022. A conference call to discuss the results will occur on August 4, 2022, at 9:00 a.m. ET. Key executives including Chairman Jeffrey Busch and CFO Robert Kiernan will host the call. Interested parties can access the call via webcast or through a dial-in number. A replay will be available starting at 12:00 p.m. ET on August 4 until midnight on August 18, 2022.
Global Medical REIT (NYSE: GMRE) announced the declaration of its second-quarter dividends for 2022. Shareholders will receive a cash dividend of $0.21 per share of common stock on July 8, 2022, with a record date of June 24, 2022. The Series A Preferred Dividend is set at $0.46875 per share, payable on August 1, 2022, with a record date of July 15, 2022. This reflects the company's ongoing commitment to reward its investors.
Global Medical REIT (NYSE: GMRE) reported a strong first quarter of 2022, with net income attributable to common stockholders reaching $2.7 million, or $0.04 per diluted share, up from $1.8 million in the same period last year. Total revenue rose by 16.5% year-over-year to $31.9 million, driven by four completed acquisitions totaling $24 million at a 7.2% cap rate. Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO) stood at $16.0 million and $16.8 million, respectively. The company remains well-positioned with approximately $1.4 billion in assets and a solid balance sheet.
Global Medical REIT Inc. (NYSE: GMRE) announced its plans to release first quarter 2022 financial results after market close on May 4, 2022. A conference call to discuss these results will be held on May 5, 2022, at 9:00 a.m. Eastern Time, featuring CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the call via a live webcast on the company’s investor website. A replay will be available starting 12:00 p.m. Eastern Time on the same day, lasting until midnight Eastern Time on May 19, 2022.
Global Medical REIT (NYSE: GMRE) has announced its first quarter 2022 cash dividends for common and preferred stock. The common dividend is set at $0.21 per share, payable on April 8, 2022 to stockholders of record by March 25, 2022. Additionally, a quarterly dividend of $0.46875 per share will be paid on Series A Preferred Stock on May 2, 2022, for stockholders recorded by April 15, 2022. GMRE focuses on acquiring and leasing medical office facilities to leading healthcare providers.
Global Medical REIT (NYSE: GMRE) reported robust financial results for 2021, with a 23.7% year-over-year revenue increase to $115.9 million. The company achieved a net income of $11.8 million, up from a loss of $7.7 million the previous year. Fourth quarter earnings showed net income of $3.8 million, or $0.06 per diluted share, alongside FFO of $0.23 per share. GMRE invested $196 million in medical real estate, including new acquisitions and expansions, with a weighted average cap rate of 7.6%. The company maintained a strong balance sheet with a leverage ratio of 43% and an unutilized borrowing capacity of $222.5 million.
Global Medical REIT Inc. (NYSE: GMRE) announced its plan to release fourth quarter and year-end 2021 financial results on February 28, 2022, after market close. A conference call will follow on March 1, 2022, at 9:00 a.m. ET, hosted by CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Participants can access the call via webcast at the company’s investor section or by dialing in. The replay will be available from 12:00 p.m. ET on March 1 to midnight ET on March 15. More information can be found on their official website.
Global Medical REIT (NYSE: GMRE) has released its inaugural Corporate Social Responsibility Report, highlighting its commitment to environmental, social, and governance (ESG) initiatives. The report outlines the Company’s efforts since 2019 to track tenant energy and water usage, achieving a significant increase in participation from 11% to approximately 51%. Additionally, GMRE improved its GRESB assessment score from 21 in 2019 to 42 in 2020. The report emphasizes the Company’s sustainability vision based on alignment, access, and authenticity, showcasing programs to support community health and governance practices focused on integrity.
Global Medical REIT (NYSE: GMRE) announced that the federal income tax treatment of dividends paid in 2021 is now available on their website. Stockholders should review their Forms 1099 and other tax statements from their brokerage firms to ensure accuracy. Consulting with tax advisors regarding individual tax implications is recommended. The REIT focuses on owning and leasing healthcare facilities to reputable healthcare systems.
Global Medical REIT (NYSE: GMRE) has declared a fourth quarter cash dividend of $0.205 per share for common stock, to be paid on January 10, 2022 to shareholders on record as of December 27, 2021.
The company also announced a preferred dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, payable on January 31, 2022 to stockholders on record as of January 15, 2022.